Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
106.23 USD
-0.62%
Updated:
Apr 25, 2024
Abbott Laboratories
Accounts Payable
|
Abbott Laboratories
Accounts Payable Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Payable
$4.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Payable
$5.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Payable
$942m
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
14%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Accounts Payable
$1.4B
|
CAGR 3-Years
91%
|
CAGR 5-Years
59%
|
CAGR 10-Years
15%
|
|
|
Stryker Corp
NYSE:SYK
|
Accounts Payable
$1.5B
|
CAGR 3-Years
23%
|
CAGR 5-Years
19%
|
CAGR 10-Years
17%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Payable
$188.7m
|
CAGR 3-Years
22%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
See Also
What is Abbott Laboratories's Accounts Payable?
Accounts Payable
4.3B
USD
4.3B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Accounts Payable amounts to 4.3B USD.
What is Abbott Laboratories's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
15%
15%
Over the last year, the Accounts Payable growth was 3%. The average annual Accounts Payable growth rates for Abbott Laboratories have been 2% over the past three years , 7% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
